Stefania Colarusso

860 total citations
16 papers, 619 citations indexed

About

Stefania Colarusso is a scholar working on Hepatology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Stefania Colarusso has authored 16 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Stefania Colarusso's work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Stefania Colarusso is often cited by papers focused on Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Stefania Colarusso collaborates with scholars based in Italy and United States. Stefania Colarusso's co-authors include Frank Narjes, Victor G. Matassa, Raffaele De Francesco, Uwe Koch, Benjamin Gerlach, Sergio Altamura, Christian Steinkühler, Mirko Brunetti, Konrad F. Koehler and Stefania Di Marco and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Stefania Colarusso

16 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Colarusso Italy 12 295 218 184 174 144 16 619
Élise Ghiro Canada 11 251 0.9× 258 1.2× 210 1.1× 166 1.0× 120 0.8× 15 582
Vida Gorys Canada 14 347 1.2× 419 1.9× 296 1.6× 230 1.3× 139 1.0× 21 827
Norman Aubry Canada 14 162 0.5× 129 0.6× 255 1.4× 133 0.8× 86 0.6× 23 545
Benjamin Gerlach Germany 10 138 0.5× 153 0.7× 221 1.2× 65 0.4× 60 0.4× 16 560
Keith F. McDaniel United States 17 207 0.7× 413 1.9× 281 1.5× 175 1.0× 196 1.4× 37 861
Murray D. Bailey Canada 15 465 1.6× 609 2.8× 321 1.7× 273 1.6× 230 1.6× 25 1.2k
John Pichardo United States 15 205 0.7× 153 0.7× 163 0.9× 146 0.8× 120 0.8× 30 458
Longhu Zhou United States 21 152 0.5× 609 2.8× 279 1.5× 253 1.5× 155 1.1× 55 986
Ted Halmos Canada 12 451 1.5× 202 0.9× 255 1.4× 252 1.4× 215 1.5× 15 747
Ashok Arasappan United States 17 147 0.5× 346 1.6× 203 1.1× 122 0.7× 83 0.6× 31 559

Countries citing papers authored by Stefania Colarusso

Since Specialization
Citations

This map shows the geographic impact of Stefania Colarusso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Colarusso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Colarusso more than expected).

Fields of papers citing papers by Stefania Colarusso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Colarusso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Colarusso. The network helps show where Stefania Colarusso may publish in the future.

Co-authorship network of co-authors of Stefania Colarusso

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Colarusso. A scholar is included among the top collaborators of Stefania Colarusso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Colarusso. Stefania Colarusso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Colarusso, Stefania, Federica Ferrigno, Immacolata Conte, et al.. (2022). SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. Bioorganic & Medicinal Chemistry. 57. 116631–116631. 6 indexed citations
2.
Yousif, Ali Munaim, Stefania Colarusso, & Elisabetta Bianchi. (2022). Katritzky Salts for the Synthesis of Unnatural Amino Acids and Late‐Stage Functionalization of Peptides. European Journal of Organic Chemistry. 26(12). 23 indexed citations
3.
Colarusso, Stefania, Mauro Cerretani, Antonino Missineo, et al.. (2020). Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction. Bioorganic & Medicinal Chemistry. 28(21). 115738–115738. 20 indexed citations
4.
Ontoria, Jesus M., Federica Ferrigno, Esther Torrente, et al.. (2020). Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction. ACS Medicinal Chemistry Letters. 11(5). 740–746. 22 indexed citations
5.
Colarusso, Stefania, Jörg Habermann, Immacolata Conte, et al.. (2011). Development of a Scalable Chiral Synthesis of MK-3281, an Inhibitor of the Hepatitis C Virus NS5B Polymerase. Synlett. 2011(11). 1527–1532. 7 indexed citations
6.
Hernando, José Ignacio Martı́n, Jesus M. Ontoria, Savina Malancona, et al.. (2009). Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase. ChemMedChem. 4(10). 1695–1713. 22 indexed citations
7.
Colarusso, Stefania, Mélina Girardin, Immacolata Conte, & Frank Narjes. (2006). Suzuki Coupling at the 2-Position of Densely Functionalized Pyrimidones. Synthesis. 2006(8). 1343–1350. 2 indexed citations
8.
Koch, Uwe, Savina Malancona, Stefania Colarusso, et al.. (2006). 2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as Inhibitors of the Hepatitis C Virus NS5B Polymerase:  Discovery, SAR, Modeling, and Mutagenesis. Journal of Medicinal Chemistry. 49(5). 1693–1705. 72 indexed citations
9.
Colarusso, Stefania, Savina Malancona, Steven J. Harper, et al.. (2006). Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. ARKIVOC. 2006(7). 479–495. 5 indexed citations
10.
Malancona, Savina, Stefania Colarusso, Jesus M. Ontoria, et al.. (2004). SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 14(17). 4575–4579. 20 indexed citations
11.
Stansfield, Ian, Stefania Colarusso, Nadia Gennari, et al.. (2004). Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid. Bioorganic & Medicinal Chemistry Letters. 14(20). 5085–5088. 31 indexed citations
12.
Colarusso, Stefania, Benjamin Gerlach, Uwe Koch, et al.. (2002). Evolution, synthesis and SAR of tripeptide α-ketoacid Inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 12(4). 705–708. 40 indexed citations
13.
Narjes, Frank, Konrad F. Koehler, Uwe Koch, et al.. (2002). A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 12(4). 701–704. 155 indexed citations
14.
Colarusso, Stefania, Uwe Koch, Benjamin Gerlach, et al.. (2002). Phenethyl Amides as Novel Noncovalent Inhibitors of Hepatitis C Virus NS3/4A Protease:  Discovery, Initial SAR, and Molecular Modeling. Journal of Medicinal Chemistry. 46(3). 345–348. 32 indexed citations
15.
Marco, Stefania Di, Menico Rizzi, Cinzia Volpari, et al.. (2000). Inhibition of the Hepatitis C Virus NS3/4A Protease. Journal of Biological Chemistry. 275(10). 7152–7157. 107 indexed citations
16.
Narjes, Frank, Mirko Brunetti, Stefania Colarusso, et al.. (2000). α-Ketoacids Are Potent Slow Binding Inhibitors of the Hepatitis C Virus NS3 Protease. Biochemistry. 39(7). 1849–1861. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026